Limoniastrum monopetalum -Mediated Nanoparticles and Biomedicines: In Silico Study and Molecular Prediction of Biomolecules

• Published in: Molecules (Basel, Switzerland) Switzerland), 2022-11, Vol.27 (22), p.8014
• Main Authors: Mohammed, Afrah E, Alghamdi, Sahar S, Alharbi, Nada K, Alshehri, Fatma, Suliman, Rasha Saad, Al-Dhabaan, Fahad, Alharbi, Maha
• Format: Article
• Language: English
• Subjects: Acids; Anti-Bacterial Agents - pharmacology; Antibacterial activity; Antibiotics; antimicrobial; Antimicrobial agents; Bacteria; Bacterial diseases; Biocompatibility; Biomolecules; Catechin; Chemical compounds; Chlorogenic acid; Computer applications; Drug resistance; Enzymes; FDA approval; Ferulic acid; Gallic acid; Humans; Internet; Metabolites; Metal Nanoparticles; molecular docking; Nanoparticles; pharmacokinetic prediction; Pharmacology; Phytochemicals; Plant Extracts - pharmacology; Plumbaginaceae; Predictions; Servers; Silver; Silver - pharmacology; silver nanoparticles; Toxicity
• ISSN: 1420-3049; 1420-3049
• DOI: 10.3390/molecules27228014

An in silico approach applying computer-simulated models helps enhance biomedicines by sightseeing the pharmacology of potential therapeutics. Currently, an in silico study combined with in vitro assays investigated the antimicrobial ability of and silver nanoparticles (AgNPs) fabricated by its aid. AgNPs mediated by were characterized using FTIR, TEM, SEM, and DLS. metabolites were detected by QTOF-LCMS and assessed using an in silico study for pharmacological properties. The antibacterial ability of an extract and AgNPs was investigated. PASS Online predictions and the swissADME web server were used for antibacterial activity and potential molecular target metabolites, respectively. Spherical AgNPs with a 68.79 nm average size diameter were obtained. Twelve biomolecules (ferulic acid, trihydroxy-octadecenoic acid, catechin, pinoresinol, gallic acid, myricetin, 6-hydroxyluteolin, 6,7-dihydroxy-5-methoxy 7-O-β-d-glucopyranoside, methyl gallate, isorhamnetin, chlorogenic acid, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl 6-O-(6-deoxy-β-l-mannopyranosyl)-β-d-glucopyranoside) were identified. The extract and AgNPs displayed antibacterial effects. The computational study suggested that metabolites could hold promising antibacterial activity with minimal toxicity and an acceptable pharmaceutical profile. The in silico approach indicated that metabolites 8 and 12 have the highest antibacterial activity, and swissADME web server results suggested the CA II enzyme as a potential molecular target for both metabolites. Novel therapeutic agents could be discovered using in silico molecular target prediction combined with in vitro studies. Among metabolites, metabolite 12 could serve as a starting point for potential antibacterial treatment for several human bacterial infections.